Otros idiomas Edwards Lifesciences Corporation Berne S.E.

Acciones

001065343

US28176E1082

Diferido Berne S.E. Otros sitios de cotización 18:00:02 05/04/2024			Varia. Cinco días.	Varia. 1 de enero.
83,18 ^CHF	+1,86 %		-.--%	+20,95 %

20/06	Un iniciado de Edwards Lifesciences vendió acciones por valor de 492.258 dólares, según un reciente registro de la SEC	MT
17/06	EDWARDS LIFESCIENCES CORPORATION : Wolfe Research reitera su recomendación de compra	ZM

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	20/06
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	05/06
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	05/06
Sector Update: Health Care Stocks Steady Premarket Monday	03/06
Edwards Lifesciences : Autodesk, Gamestop, Nvidia... les valeurs à suivre aujourd'hui à Wall Street -	03/06
Edwards Lifesciences : cède sa filiale soins intensifs à Becton Dickison	03/06
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	03/06
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	03/06
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	03/06
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	03/06
Edwards Lifesciences to Sell Critical Care to BD	03/06
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	03/06
Edwards Lifesciences : Charter of the Audit Committee	28/05
Some of the biggest splits in Corporate America	23/05
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	13/05
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	13/05
Edwards Lifesciences hit with Meril's EU antitrust complaint	13/05
Edwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vor	09/05
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité	09/05

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Titulares

Edwards Lifesciences Corporation : La historia continúa

23 de abril 2024 a las 16:35